Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2fgi | PD1 | Fibroblast growth factor receptor 1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 1.000 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.643 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.609 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.607 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.603 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.603 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.560 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.560 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.559 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.549 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.548 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.546 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.545 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.545 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.545 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.541 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.536 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.536 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.536 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.535 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.534 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.534 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.534 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.534 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.531 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.529 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.528 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.525 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.525 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.525 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.525 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.525 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.523 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.523 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.522 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.521 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.521 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.519 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.518 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.518 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.518 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.517 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.517 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.517 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.516 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.516 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.515 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.514 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.514 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.514 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.512 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.511 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.511 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.510 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.509 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.509 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.506 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.505 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.505 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.505 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.504 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.504 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.504 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.503 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.503 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.502 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.502 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.501 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.501 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.500 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.500 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.499 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.499 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.499 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.499 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.498 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.498 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.498 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.497 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.497 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.497 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.496 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.496 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.496 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.496 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.496 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.496 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.496 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.495 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.494 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.494 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.494 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.493 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.493 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.492 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.492 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.492 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.492 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.492 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.491 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.491 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.490 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.490 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.490 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.490 | |
| 2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.490 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.490 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.490 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.489 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.488 | |
| 3bhy | 7CP | Death-associated protein kinase 3 | / | 0.488 | |
| 3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.488 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.488 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.488 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.488 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.487 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.487 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.487 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.487 | |
| 4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.487 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.487 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.486 | |
| 3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.486 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.486 | |
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.485 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.485 | |
| 2buj | STU | Serine/threonine-protein kinase 16 | / | 0.484 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.484 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.482 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.482 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.481 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.481 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.480 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.480 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.479 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.479 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.478 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.478 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.478 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.477 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.477 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.477 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.477 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.477 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
| 3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
| 4eqc | XR1 | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.476 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.476 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.475 | |
| 3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.474 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.474 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.474 | |
| 4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.474 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.474 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.473 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.473 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.473 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.472 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.471 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.471 | |
| 3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.471 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.471 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.471 | |
| 2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.470 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.470 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.469 | |
| 2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.469 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.469 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.469 | |
| 3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.469 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.469 | |
| 1hpo | UNI | Gag-Pol polyprotein | 3.4.23.16 | 0.468 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.468 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
| 3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.468 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.468 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.468 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.468 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.467 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.467 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.467 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.467 | |
| 4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.467 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.467 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.466 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.466 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.466 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.466 | |
| 1hnc | GDN | Glutathione S-transferase Mu 2 | 2.5.1.18 | 0.465 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.465 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.465 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
| 1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.464 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.464 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.463 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.463 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.462 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.462 | |
| 2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.462 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.462 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.462 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.462 | |
| 2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.461 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
| 3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.461 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.461 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.461 | |
| 2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.460 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.460 | |
| 2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.460 | |
| 1ie4 | T44 | Transthyretin | / | 0.459 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.459 | |
| 2gst | GPS | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.459 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.459 | |
| 3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.459 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.459 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.459 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.459 | |
| 4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 4qmu | SKE | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.459 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.459 | |
| 2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.458 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 3zok | NAD | 3-dehydroquinate synthase, chloroplastic | 4.2.3.4 | 0.458 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.458 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.458 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.457 | |
| 2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.457 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.457 | |
| 2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.457 | |
| 3a2o | KNJ | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.457 | |
| 4aw5 | 30K | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
| 4e37 | NDP | Catalase | 1.11.1.6 | 0.457 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.457 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.456 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.455 | |
| 3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.455 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.455 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.454 | |
| 3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.454 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.454 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
| 4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.453 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.453 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.453 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.453 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.452 | |
| 3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.452 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.452 | |
| 4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.452 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.451 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.451 | |
| 3ekv | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.451 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 4k2x | FAD | Polyketide oxygenase/hydroxylase | / | 0.451 | |
| 4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.451 | |
| 4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.451 | |
| 1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.450 | |
| 1t7i | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.450 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.450 | |
| 2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.450 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.450 | |
| 3oxv | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.450 | |
| 2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
| 2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
| 2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.449 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 4u8i | FDA | UDP-galactopyranose mutase | / | 0.449 | |
| 5dc5 | B3N | Histone deacetylase 8 | 3.5.1.98 | 0.449 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 1t0l | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.448 | |
| 2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.448 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.448 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.448 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.448 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.448 | |
| 4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.448 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.448 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 1jld | 0PP | Gag-Pol polyprotein | / | 0.447 | |
| 1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.447 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.447 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.447 | |
| 2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.447 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.447 | |
| 3ics | COA | Coenzyme A disulfide reductase | / | 0.447 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.447 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.447 | |
| 4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.447 | |
| 4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
| 3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.446 | |
| 3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.446 | |
| 4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.446 | |
| 4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.446 | |
| 6gsw | GPS | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.446 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.445 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 3iqe | F42 | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.445 | |
| 3s43 | 478 | Protease | / | 0.445 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.445 | |
| 5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.445 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 1rx3 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.444 | |
| 2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.444 | |
| 2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.444 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.444 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.444 | |
| 1bve | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 1dq8 | COA | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.443 | |
| 1ebk | 0Q4 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.443 | |
| 1w5v | BE3 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2yw2 | ATP | Phosphoribosylamine--glycine ligase | / | 0.443 | |
| 3fl8 | RAR | Dihydrofolate reductase | / | 0.443 | |
| 3q92 | XNB | Ketohexokinase | / | 0.443 | |
| 3qai | XNN | Ketohexokinase | / | 0.443 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.443 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.443 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.443 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.442 | |
| 1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.442 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.442 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.442 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 1kr2 | TAD | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 | 2.7.7.1 | 0.441 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 2hw1 | ANP | Ketohexokinase | / | 0.441 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.441 | |
| 2w4i | VGA | Glutamate racemase | / | 0.441 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 3dtc | VIN | Mitogen-activated protein kinase kinase kinase 9 | 2.7.11.25 | 0.441 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3s54 | 017 | Protease | / | 0.441 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 3w2c | N15 | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.441 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.441 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.441 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
| 4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.441 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 1chw | HXC | Chalcone synthase 2 | 2.3.1.74 | 0.440 | |
| 1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.440 | |
| 1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 2gej | GDD | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.440 | |
| 2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.440 | |
| 3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.440 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3ogq | AB1 | Pol polyprotein | / | 0.440 | |
| 4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.440 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.440 | |
| 4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.440 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.440 | |
| 5dhh | DGW | Nociceptin receptor | / | 0.440 |